You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
It anticipates using the funds to complete the development of its first set of diagnostic products, and for a set of clinical studies to obtain regulatory clearance.
The financing will be used to hire additional team members and conduct additional studies in fertility science. The firm also launched its $199 fertility test.
Illumina Ventures was the sole investor in the Series A1 round, which will go toward Cernostics' clinical and market development studies for its TissueCypher Barrett's Esophagus assay.
The companies partnered last month to develop new personalized cancer diagnostics using the Helomics D-Chip bioinformatics platform.
The company will use the money to bring its Elsie genomic information platform to markets internationally.
The new funding comes from life sciences investment firm Perceptive Advisors. Home Care Assistance CEO Lily Sarafan has also joined Counsyl's board.
The financing will be used to launch Aquaro's first product, an automated microtomy technology, expand the firm's commercial efforts, and support R&D.
BOE Technology led the financing round, with participation from family offices, current investors, and the North Carolina Biotechnology Center.
The investment is part of a Series C financing round that will also include other investors. Seventh Sense is developing a new type of blood collection device to improve patient compliance.
The funding will go toward bringing the BA100 test to clinicians. The test can identify patients most likely to respond to the standard of care chemotherapy treatment.